![[ Visit Client Website ]](images/banner.gif)
Evidence for effective prevention amassed over the past three decades is now being harnessed in diverse initiatives involving large scale investments by public and private funders. Evidence of efficacy, costs, and return on investment each have a role in driving these investments, with the overall aim to build healthier communities and improve lives. This invited symposium will highlight three approaches to scaling evidence-based prevention, discuss how evidence is used to support investment, and describe the results. Panelists will describe the large scale investment strategy they are involved in and address one or more of the following issues: (1) What types of evidence is persuasive to investors interested in scaling effective prevention? (2) What are rigorous evaluation strategies for assessing the impacts of public and private investments in prevention at scale? (3) How does evidence of costs and benefits help drive public and private investments in evidence-based prevention? (4) What are the results of these large-scale investments? After the presentations the discussant will comment on evidence and investment at scale.
Family Connects: Evidence and Insights from a Universal Approach to Home Visiting
W. Benjamin Goodman, PhD, Research Scientist, Center for Child and Family Policy, Duke University
Planned and Unplanned Variation in Head Start: Evidence from a 50 State Study to Inform Policy
W. Steven Barnett, PhD, Board of Governors Professor and Director of the National Institute for Early Education Research, Rutgers University
The Role of Impact and Economic Evidence in Pay for Success Financing
Janis Dubno, MBA, Director, Sorenson Impact Center, David Eccles School of Business, University of Utah
Discussant
John Thomas Tambornino, PhD, Senior Advisor, Evidence Team/Office of Economic Policy, White House Office of Management and Budget